Jean Jacques Bienaime, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 1,000 shares at $90.35 ($90K) on 2024-02-27, disclosed to the SEC on 2024-02-29.
Seasonal sale ($90k) by Director — this insider has traded BMRN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |